Literature DB >> 12826087

Anxiety disorders and other psychiatric subgroups in patients complaining of dizziness.

A Eckhardt-Henn1, P Breuer, C Thomalske, S O Hoffmann, H C Hopf.   

Abstract

Two hundred and two consecutive patients with dizziness were evaluated using blind neuro-otological testing and examination, blind psychiatric examination, including structured interviews (according to DSM-IV), the Symptom Check-List (SCL 90 R), and the State-Trait Anxiety Inventory (STAI). In 28% of the patients (N=50) dizziness was of organic origin (O group); in 55.3% (N=99) of psychogenic origin (P group) and in 16.8% comorbid psychiatric disorders were found (Mixed group). In 5.3% (N=10) neither organic nor psychiatric results could be found, which could explain the dizziness (Ideopathic group). Compared with the Organic group the patients with psychiatric disorders (P and Mixed group) had much more extensive workups for dizziness, intense emotional distress (anxiety, depression), greater handicaps, and high somatization scores. In the P and Mixed groups three main subgroups of psychiatric disorders could be found: anxiety (N=56), depressive (N=20), and somatoform disorders (N=53). Patients with anxiety and depressive disorders showed the greatest emotional distress and handicaps. The results indicate that psychiatric disorders, above all anxiety disorders, should be included in the differential diagnosis in patients with a long duration of dizziness and great handicaps. An interdisciplinary treatment (including psychiatric treatment) would be superior to an exclusive somatic one.

Entities:  

Mesh:

Year:  2003        PMID: 12826087     DOI: 10.1016/s0887-6185(02)00226-8

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  32 in total

Review 1.  The demystification of autoscopic phenomena: experimental propositions.

Authors:  Christine Mohr; Olaf Blanke
Journal:  Curr Psychiatry Rep       Date:  2005-06       Impact factor: 5.285

2.  Tailored care for somatoform vertigo/dizziness: study protocol for a randomised controlled trial evaluating integrative group psychotherapy.

Authors:  Claas Lahmann; P Henningsen; M Dieterich; K Radziej; G Schmid
Journal:  J Neurol       Date:  2015-05-23       Impact factor: 4.849

3.  The Munich Diagnostic and Predictor Study of Dizziness: objectives, design, and methods.

Authors:  C Lahmann; P Henningsen; M Dieterich; R Feuerecker; C A Cyran; G Schmid
Journal:  J Neurol       Date:  2011-09-23       Impact factor: 4.849

4.  Factors associated with balance confidence in older adults with health conditions affecting the balance and vestibular system.

Authors:  Gregory F Marchetti; Susan L Whitney; Mark S Redfern; Joseph M Furman
Journal:  Arch Phys Med Rehabil       Date:  2011-11       Impact factor: 3.966

5.  Transcranial direct current stimulation (tDCS) for treatment of phobic postural vertigo: an open label pilot study.

Authors:  Ulrich Palm; Valerie Kirsch; Hanna Kübler; Nina Sarubin; Daniel Keeser; Frank Padberg; Marianne Dieterich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-04-06       Impact factor: 5.270

Review 6.  [Management of the patient with Meniere's disease. Clear diagnosis but vertigo-provoking perspective].

Authors:  H Schaaf; H Holtmann
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

Review 7.  [Somatoform vertigo syndrome].

Authors:  A Eckhardt-Henn; R Tschan; C Best; M Dieterich
Journal:  Nervenarzt       Date:  2009-08       Impact factor: 1.214

8.  Is psychogenic dizziness the exact diagnosis?

Authors:  Fazil Necdet Ardiç; Figen Culha Ateşci
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-18       Impact factor: 2.503

9.  Psychiatric morbidity and comorbidity in different vestibular vertigo syndromes. Results of a prospective longitudinal study over one year.

Authors:  Christoph Best; Annegret Eckhardt-Henn; Regine Tschan; Marianne Dieterich
Journal:  J Neurol       Date:  2009-02-07       Impact factor: 4.849

10.  Validation of the German version of the Vertigo Symptom Scale (VSS) in patients with organic or somatoform dizziness and healthy controls.

Authors:  R Tschan; J Wiltink; C Best; S Bense; M Dieterich; M E Beutel; A Eckhardt-Henn
Journal:  J Neurol       Date:  2008-05-16       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.